Page last updated: 2024-11-02

oxidopamine and EHS Tumor

oxidopamine has been researched along with EHS Tumor in 1 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lackovicova, L1
Banovska, L1
Bundzikova, J1
Janega, P1
Bizik, J1
Kiss, A1
Mravec, B1

Other Studies

1 other study available for oxidopamine and EHS Tumor

ArticleYear
Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats.
    Neoplasma, 2011, Volume: 58, Issue:5

    Topics: Animals; Body Weight; Fibrosarcoma; Humans; Immunoenzyme Techniques; Injections, Intraperitoneal; Ma

2011